We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Spain to Host the 15th Congress of the EHA

By LabMedica International staff writers
Posted on 20 May 2010
More than 8,000 participants from around 100 European and non-European countries will gather at the 15th Congress of the European Hematology Association (EHA) at Fira de Barcelona (Barcelona, Spain) from June 10-13, 2010.

The EHA Congress is a forum for laboratory and clinical hematologists and presents the latest results in basic and clinical research. The program includes basic and translational science, clinical trials, diagnostic techniques, a major education program, and ethical and regulatory issues. The topics range from stem cells to leukemia, lymphoma and myeloma, thrombosis and bleeding disorders, and transfusion.

The EHA aims to promote excellence in clinical practice, research, and education in European hematology. EHA was founded in June 1992 and today is a consolidated representative of European hematologists.

Press briefing for the EHA Congress will be held at 8:30 a.m. - 9:30 a.m. on Friday June 11, 2010, at the Fera de Barcelona. Hematologists and other experts will present an overview of the future and expected developments within their fields of expertise.

Related Links:
15th Congress of the European Hematology Association




New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test
New
Biological Indicator Vials
BI-O.K.

Latest Hematology News

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

WBC Count Could Predict Severity of COVID-19 Symptoms



Sekisui Diagnostics UK Ltd.